A New Approach for the Prevention and Treatment of Cardiovascular Disorders. Molecular Hydrogen Significantly Reduces the Effects of Oxidative Stress
- PMID: 31159153
- PMCID: PMC6600250
- DOI: 10.3390/molecules24112076
A New Approach for the Prevention and Treatment of Cardiovascular Disorders. Molecular Hydrogen Significantly Reduces the Effects of Oxidative Stress
Abstract
Cardiovascular diseases are the most common causes of morbidity and mortality worldwide. Redox dysregulation and a dyshomeostasis of inflammation arise from, and result in, cellular aberrations and pathological conditions, which lead to cardiovascular diseases. Despite years of intensive research, there is still no safe and effective method for their prevention and treatment. Recently, molecular hydrogen has been investigated in preclinical and clinical studies on various diseases associated with oxidative and inflammatory stress such as radiation-induced heart disease, ischemia-reperfusion injury, myocardial and brain infarction, storage of the heart, heart transplantation, etc. Hydrogen is primarily administered via inhalation, drinking hydrogen-rich water, or injection of hydrogen-rich saline. It favorably modulates signal transduction and gene expression resulting in suppression of proinflammatory cytokines, excess ROS production, and in the activation of the Nrf2 antioxidant transcription factor. Although H2 appears to be an important biological molecule with anti-oxidant, anti-inflammatory, and anti-apoptotic effects, the exact mechanisms of action remain elusive. There is no reported clinical toxicity; however, some data suggests that H2 has a mild hormetic-like effect, which likely mediate some of its benefits. The mechanistic data, coupled with the pre-clinical and clinical studies, suggest that H2 may be useful for ROS/inflammation-induced cardiotoxicity and other conditions.
Keywords: heart transplantation; ischemia/reperfusion injury; molecular hydrogen; oxidative stress; radiation-induced heart disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Slezak J., Kura B., Babal P., Barancik M., Ferko M., Frimmel K., Kalocayova B., Kukreja R.C., Lazou A., Mezesova L., et al. Potential markers and metabolic processes involved in the mechanism of radiation-induced heart injury. Can. J. Physiol. Pharmacol. 2017;95:1190–1203. doi: 10.1139/cjpp-2017-0121. - DOI - PubMed
-
- Eurostat. [(accessed on 14 August 2016)]; Available online: https://ec.europa.eu/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
